D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
STRO holding history
Sutro Biopharma, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
STRO overviewAll 13F holders of STROFull Q2 2026 holdings
- Shares (Q2 2026)
- 30,128
- Value
- $1.00M
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 30,128 | $1.00M | <0.1% | +30,128 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −158,037−100.0% | Sold out | Holders |
| Q1 2025 | 158,037 | $102.8K | <0.1% | +354+0.2% | Added | Holders |
| Q4 2024 | 157,683 | $290.1K | <0.1% | −9,962−5.9% | Reduced | Holders |
| Q3 2024 | 167,645 | $580.1K | <0.1% | +38,980+30.3% | Added | Holders |
| Q2 2024 | 128,665 | $377.0K | <0.1% | −112,978−46.8% | Reduced | Holders |
| Q1 2024 | 241,643 | $1.37M | <0.1% | +241,643 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −40,723−100.0% | Sold out | Holders |
| Q2 2023 | 40,723 | $189.4K | <0.1% | −114,476−73.8% | Reduced | Holders |
| Q1 2023 | 155,199 | $717.0K | <0.1% | −120,392−43.7% | Reduced | Holders |
| Q4 2022 | 275,591 | $2.23M | <0.1% | −39,423−12.5% | Reduced | Holders |
| Q3 2022 | 315,014 | $1.75M | <0.1% | +55,617+21.4% | Added | Holders |
| Q2 2022 | 259,397 | $1.35M | <0.1% | +259,397 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −30,664−100.0% | Sold out | Holders |
| Q4 2021 | 30,664 | $456.0K | <0.1% | −6,723−18.0% | Reduced | Holders |
| Q3 2021 | 37,387 | $706.0K | <0.1% | +8,410+29.0% | Added | Holders |
| Q2 2021 | 28,977 | $539.0K | <0.1% | −13,629−32.0% | Reduced | Holders |
| Q1 2021 | 42,606 | $970.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.